← Browse by Condition
Medical Condition
metastatic esophageal carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for metastatic esophageal carcinoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
NCT04221893
Recruiting
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Enrollment
28 pts
Location
United States
Sponsor
University of California, San ...
NCT06251973 Phase 2
Recruiting
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
Enrollment
37 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology